^{31}P and ^{75}As NMR evidence for a residual density of states at zero energy in superconducting BaFe_2(As_{0.67}P_{0.33})_2

^{31}P and ^{75}As NMR measurements were performed in superconducting BaFe_2(As_{0.67}P_{0.33})_2 with T_c = 30 K. The nuclear-spin-lattice relaxation rate T_1^{-1} and the Knight shift in the normal state indicate the development of antiferromagnetic fluctuations, and T_1^{-1} in the superconducting (SC) state decreases without a coherence peak just below T_c, as observed in (Ba_{1-x}K_{x})Fe_2As_2. In contrast to other iron arsenide superconductors, the T_1^{-1} \propto T behavior is observed below 4K, indicating the presence of a residual density of states at zero energy. Our results suggest that strikingly different SC gaps appear in BaFe_2(As_{1-x}P_{x})_2 despite a comparable T_c value, an analogous phase diagram, and similar Fermi surfaces to (Ba_{1-x}K_{x})Fe_2As_2.Comment: 4 pages, 5 figure

Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actomycin D, cyclophosphamide and vincristine (EMA-CO) chemotherapy.

It is well known that antecedent term delivery and metastasis to sites other than the lungs and vagina are high risk factors for patients with gestational trophoblastic neoplasia. Here we report on a patient with choriocarcinoma who presented with brain and lung metastases after term delivery and was treated by EMA-CO chemotherapy. A 31-year-old woman delivered a healthy infant at term. Frequent episodes of hemoptysis occurred beginning 3 weeks after the delivery. On admission to our hospital, she had lesions in the uterus, lungs and brain as well as motor aphasia and hemiplagia. The pretreatment beta-hCG level was 21,000 ng/ml and the WHO score was 16 (high-risk group). The EMA-CO regimen was administrated as first-line chemotherapy and the patient achieved complete remission after 7 courses. Treatment was terminated after 11 courses and maintained with etoposide (25 mg/day) for 6 months. The patient has remained in complete remission for more than 16 years without other adjuvant therapies. We believe that EMA-CO can currently be considered the regimen of first choice for most high-risk patients with gestational trophoblastic neoplasia in view of its effectiveness and excellent tolerability.</p

Automated Evaluation of Coordinated Movement of Fingers Using Home Rehabilitation Device

Home rehabilitation is much in need in ageing societies. Especially, for hemiplegia patients who have paralysis at fingers, it is known that long continuous rehabilitation is effective for recovery. To automate home rehabilitation without the help of a medical specialist, it is desirable not only to provide a rehabilitation procedure but also to give the condition of the paralysis of the patient. In our previous studies, we proposed a robotic device to foster separative voluntary finger lift movement. The device mounts pressure sensors at each finger to monitor the degree of unwanted finger movements. However, it is not clear which is an effective way to measure the condition of paralysis by these finger pressure time series data. In this paper, we propose a new measurement method that is based on the “coordinated movement” of fingers. A patient is asked to perform 4 tasks: pinch2 (pinch movement by index finger and thumb), pinch3 (pinch movement by index, middle and thumb), grasp2 (grasp movement by the ring and little finger), and grasp3 (grasp movement by the middle, ring, and little finger). All pressure time series of finger movements are quantified their dissimilarities with data of standard healthy subjects. We found that the grasp3 has the largest correspondence relation with the degree of paralysis

Evaluation of Forearm Musclar Function of Hemiplegic Patients Using Displacement MMG

To realise an automated self-rehabilitation at home, it is necessary to provide proper feedback on the status of the recovery of the patient. In a simple finger rehabilitation, a fingertip force monitor is used to detect undesired and paralyzed movement, which is used to determine the degree of recovery. In contrast to the fingertip force, the balance of flexion and extension of finger muscles is another essential feature of the paralysis. However, simultaneous monitoring of flexor and extensor is impossible by using a single fingertip pressure sensor. Usually, EMG is used to monitor individual muscular activity. However, inexperienced home user will not be able to deal with electrodes properly. In this paper, we propose a device to monitor flexion and extension by a unit which is easy to handle. Also, we propose a method to derive a degree of recovery using the signals collected from this device. The results by data collected from healthy and stroke patients show the potential effectiveness of our method